BioAge Labs
BIOA
67 hedge funds and large institutions have $76.2M invested in BioAge Labs in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 12 closing their positions.
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
3% more funds holding
Funds holding: 65 → 67 (+2)
1.78% more ownership
Funds ownership: 54.79% → 56.57% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
33% less capital invested
Capital invested by funds: $114M → $76.2M (-$37.6M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $765K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$3.92M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.58M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$334K |
| 5 |
State Street
Boston,
Massachusetts
|
+$266K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.91M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.19M |
| 3 |
Goldman Sachs
New York
|
-$782K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$398K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$346K |
BIOA Hedge Fund Activity: Q1 2025 in Review
67 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q1 2025, worth a combined $76.2M — down 33% from $114M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new BIOA positions and 12 closed out — a net gain of 2 holders — while 17 added to existing stakes and 18 trimmed.
The largest buyer was ADAR1 Capital Management, adding an estimated $3.92M. The largest seller was Morgan Stanley, cutting an estimated $1.91M.
- 67 institutional investors held BioAge Labs (BIOA) as of Q1 2025, up from 65 in Q4 2024.
- Funds reported $76.2M of BioAge Labs stock for Q1 2025, down 33% quarter-over-quarter.
- 14 funds opened new BioAge Labs positions in Q1 2025 and 12 closed out, a net change of +2 holders.
- The largest BioAge Labs buyer in Q1 2025 was ADAR1 Capital Management, an estimated $3.92M added.
- The largest BioAge Labs seller in Q1 2025 was Morgan Stanley, an estimated $1.91M sold.
Based on aggregated 13F filings for Q1 2025.